Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

